Bridget O'Keeffe, based in San Francisco, CA, US, is currently a Senior Vice President Clinical Development at Ambrx, bringing experience from previous roles at OncoSec, Nektar Therapeutics, Calithera Biosciences and Achaogen. Bridget O'Keeffe holds a 1997 - 2003 PhD in Molecular and Cell Biology @ University of California, Berkeley. With a robust skill set that includes Oncology, Biotechnology, Clinical Development, Clinical Research, Clinical Trials and more, Bridget O'Keeffe contributes valuable insights to the industry. Bridget O'Keeffe has 2 emails and 1 mobile phone number on RocketReach.